Search
                    Connecticut Paid Clinical Trials
A listing of 1248  clinical trials  in Connecticut  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1141 - 1152 of 1248
        
                Connecticut is currently home to 1248 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New Haven, Hartford, Farmington and Stamford. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    Evaluating the Community Drum Circle
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased America due to disproportionate effects of social factors such as racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of Persons of African Descent(PAD) or other marginalized groups and are not designed to be culturally rel...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 16 years and 65 years
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    Drum Circle Synchrony Study 2c.a.
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or co...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    Music Mindfulness Study 2a.
                                
            
            
        Recruiting
                            
            
                Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or co...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                09/17/2024
            
            Locations: BLOOM, New Haven, Connecticut         
        
        
            Conditions: Mental Health Issue, COVID-19
        
            
        
    
                
                                    A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
                                
            
            
        Recruiting
                            
            
                This is a prospective, single-arm study designed to understand the mechanisms that lead to a loss of response to influenza vaccine in older adults. The investigators will recruit and longitudinally follow a cohort of 75 older adults (65 years and older) who will receive three different influenza vaccines over three annual influenza seasons. Blood samples will be collected from the participants at sixteen study visits over three years. Nasal swab and stool samples will also be collected from part...  Read More             
        
        
    Gender:
                ALL
            Ages:
                65 years and above
            Trial Updated:
                09/17/2024
            
            Locations: UConn Health, Center On Aging, Farmington, Connecticut         
        
        
            Conditions: Aging, Influenza Vaccine, Dendritic Cell, Vaccine Response
        
            
        
    
                
                                    SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to longitudinally characterize and evaluate changes in synaptic density in the brain using novel positron-emission tomography (PET) scans; magnetic resonance imaging (MRI), and clinical laboratory markers associated with HIV-related injury in the central nervous system. This study will test hypotheses relating to the presence and mechanisms of aberrant brain structure at the synaptic level in living humans with virologically controlled HIV on antiretroviral therapy....  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                09/05/2024
            
            Locations: Yale School of Medicne, Neuro ID Research Program, New Haven, Connecticut         
        
        
            Conditions: HIV Associated Neurocognitive Disorder, HIV Dementia, HIV Encephalitis, Healthy
        
            
        
    
                
                                    Strengthening the Connections to Opportunities for Prevention Engagement
                                
            
            
        Recruiting
                            
            
                The Strengthening the Connections to Opportunities for Prevention Engagement (SCOPE) project will create a pathway for children and families from the City of Hartford to connect with a Connecticut Children's Care Coordinator (CC) in an effort to reduce levels of violence exposure.             
        
        
    Gender:
                ALL
            Ages:
                Between 8 years and 17 years
            Trial Updated:
                09/04/2024
            
            Locations: Connecticut Children's, Hartford, Connecticut         
        
        
            Conditions: Interpersonal Violence, Structural Violence
        
            
        
    
                
                                    Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
                                
            
            
        Recruiting
                            
            
                This clinical trial compares telephone-based physical activity coaching to self monitored physical activity for improving physical function in older adults who are undergoing surgery for lung cancer and their caregivers. Lung cancer surgery in older adults is associated with functional declines and unique challenges. Performing physical activity around the time of surgery has been shown to improve functional outcomes in patients and exercise programs delivered via telehealth may improve access a...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/04/2024
            
            Locations: Yale New Haven Medical Center, New Haven, Connecticut         
        
        
            Conditions: Lung Carcinoma
        
            
        
    
                
                                    Adipose Dysfunction, Imaging, Physiology, and Outcomes With Sodium Glucose Cotransporter 2 Inhibitor (SGLT2i) for Sleep Apnea: The ADIPOSA Study
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to test if bexagliflozin lowers the sleep apnea severity in adults who are overweight or obese with moderate to severe obstructive sleep apnea (OSA) compared with a placebo (look-alike substance that contains no active drug).
The main question it aims to answer is:
* If SGLT2i will reduce anatomic and physiologic traits, clinical measures of OSA and sleep deficiency in participants
* If improvement in clinical measures are because of improvement in the anatom...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                09/04/2024
            
            Locations: Yale New Haven Health, New Haven, Connecticut         
        
        
            Conditions: Sleep Apnea
        
            
        
    
                
                                    Regulating Blood Pressure During Recovery from Intracerebral Hemorrhage and Ischemic Stroke
                                
            
            
        Recruiting
                            
            
                The purpose of this research study is to determine whether blood pressure treatment regimens with spironolactone are better than blood pressure treatment regimens without spironolactone at lowering blood pressure in stroke survivors.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                08/30/2024
            
            Locations: Yale New Haven Hospital, New Haven, Connecticut         
        
        
            Conditions: Intracerebral Hemorrhage, Spironolactone, Ischemic Stroke
        
            
        
    
                
                                    CLOZAPINE Response in Biotype-1
                                
            
            
        Recruiting
                            
            
                The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The study will utilize a stringent randomized, double-blinded, parallel group clinical trial design. B2 group will serve as psychosis control with risperidone as medication control. The study is designed to evaluate effect of clozapine on the B1 participants, and the effect that will be evaluated is a biomedical outcome. The...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 60 years
            Trial Updated:
                08/27/2024
            
            Locations: Hartford Healthcare, Hartford, Connecticut         
        
        
            Conditions: Schizophrenia, Schizoaffective Disorder, Bipolar 1 Disorder
        
            
        
    
                
                                    Post Market Registry Study of the Philips QuickClear Mechanical Thrombectomy System
                                
            
            
        Recruiting
                            
            
                A post-market study of the QuickClear Mechanical Thrombectomy system used for the removal of acute Deep Vein Thrombosis (DVT) from the deep veins of legs in the setting of an office interventional suite.             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 89 years
            Trial Updated:
                08/23/2024
            
            Locations: Vascular Care Connecticut, Darien, Connecticut         
        
        
            Conditions: Acute Deep Venous Thrombosis of Ileofemoral Vein
        
            
        
    
                
                                    Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
                                
            
            
        Recruiting
                            
            
                A prospective open label, multicenter study to evaluate the feasibility and acute toxicity of using molecularly guided therapy in combination with standard therapy followed by a Randomized Controlled Trial of standard immunotherapy with or without DFMO followed by DFMO maintenance for Subjects with Newly Diagnosed High-Risk Neuroblastoma.             
        
        
    Gender:
                ALL
            Ages:
                22 years and below
            Trial Updated:
                08/21/2024
            
            Locations: Connecticut Children's Hospital, Hartford, Connecticut         
        
        
            Conditions: Neuroblastoma
        
            
        
    